Detailansicht

Wissensnetz

Person

Isabel Poschke

Name	Isabel Poschke
Ort	Heidelberg (Wirkungsort) Deutschland
Variante	Isabel C. Poschke
Weitere Angaben	post-doctoral scientist, Deutsches Krebsforschungszentrum Heidelberg
Datensatztyp	Person
GND-Nummer	1143622111
Datensatz-ID	1143622111
Beteiligt an alle anzeigen Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy A H3K27M-targeted vaccine in adults with diffuse midline glioma INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies A high‐throughput RNA i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Isabel Poschke

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy

A H3K27M-targeted vaccine in adults with diffuse midline glioma

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

A high‐throughput RNA i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes